| P50 | author | S.a Rahim Rezaee | Q42862657 |
| | Kiarash Ghazvini | Q57794555 |
| | Hadi Farsiani | Q86166322 |
| | Arman Mosavat | Q86166324 |
| P2093 | author name string | Mojtaba Sankian | |
| | Saman Soleimanpour | |
| | Zahra Meshkat | |
| | Hamid Sadeghian | |
| | Mohammad Reza Akbari Eydgahi | |
| P2860 | cites work | The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools | Q24248165 |
| | Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics | Q26822421 |
| | Vaccines against tuberculosis: where are we and where do we need to go? | Q26992233 |
| | Structure validation by Calpha geometry: phi,psi and Cbeta deviation | Q27860657 |
| | Verification of protein structures: patterns of nonbonded atomic interactions | Q29615613 |
| | T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells | Q33952975 |
| | ESAT-6 proteins: protective antigens and virulence factors? | Q33982392 |
| | IL-17 and Th17 cells in tuberculosis | Q34545889 |
| | Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice | Q34761889 |
| | Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice | Q34965575 |
| | Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells | Q35049100 |
| | An epigenetic view of helper T cell differentiation | Q35164202 |
| | A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection | Q35274924 |
| | Polymeric human Fc-fusion proteins with modified effector functions | Q35551564 |
| | HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule | Q36439241 |
| | Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. | Q36487349 |
| | Epigenetic control of T-helper-cell differentiation | Q37371624 |
| | Cytokine therapy of tuberculosis at the crossroads | Q37754962 |
| | Immunotherapy for tuberculosis: what's the better choice? | Q38015155 |
| | Fc-fusion proteins: new developments and future perspectives. | Q38029985 |
| | Vaccination against tuberculosis: how can we better BCG? | Q38068986 |
| | The immune response in tuberculosis | Q38091698 |
| | Harnessing local and systemic immunity for vaccines against tuberculosis | Q38164196 |
| | Fc fusion as a platform technology: potential for modulating immunogenicity | Q38285478 |
| | Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines | Q39614628 |
| | T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. | Q40076818 |
| | Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine | Q40296230 |
| | Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns | Q41775340 |
| | Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG. | Q44512209 |
| | Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. | Q51065721 |
| | IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10467-10480 | |
| P577 | publication date | 2015-09-15 | |
| P1433 | published in | Applied Microbiology and Biotechnology | Q13553694 |
| P1476 | title | APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice | |
| P478 | volume | 99 | |